MedPath

赤峰源生药业有限公司

Ownership
-
Established
2002-04-23
Employees
-
Market Cap
-
Website
www.cfysyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

36

NMPA:36

Drug Approvals

Compound Sodium Acetate Ringer's Injection

Product Name
复方醋酸钠林格注射液
Approval Number
国药准字H20253319
Approval Date
Jan 24, 2025
NMPA

Compound Sodium Acetate Ringer's Injection

Product Name
复方醋酸钠林格注射液
Approval Number
国药准字H20253318
Approval Date
Jan 24, 2025
NMPA

Multiple Electrolytes Injection (Ⅱ)

Product Name
复方电解质注射液(Ⅱ)
Approval Number
国药准字H20244997
Approval Date
Sep 26, 2024
NMPA

Tirofiban Hydrochloride and Sodium Chloride Injection

Product Name
盐酸替罗非班氯化钠注射液
Approval Number
国药准字H20247115
Approval Date
May 30, 2024
NMPA

Tranexamic Acid and Sodium Chloride Injection

Product Name
氨甲环酸氯化钠注射液
Approval Number
国药准字H20193138
Approval Date
Apr 16, 2024
NMPA

Moxifloxacin Hydrochloride and Sodium Chloride Injection

Product Name
盐酸莫西沙星氯化钠注射液
Approval Number
国药准字H20234509
Approval Date
Nov 21, 2023
NMPA

Ambroxol Hydrochloride and Glucose Injection

Product Name
盐酸氨溴索葡萄糖注射液
Approval Number
国药准字H20133183
Approval Date
Jun 12, 2023
NMPA

Fluconazole and Sodium Chloride Injection

Product Name
氟康唑氯化钠注射液
Approval Number
国药准字H20123403
Approval Date
Dec 16, 2022
NMPA

Metronidazole and Sodium Chloride Injection

Product Name
甲硝唑氯化钠注射液
Approval Number
国药准字H20123229
Approval Date
Aug 8, 2022
NMPA

Metronidazole and Sodium Chloride Injection

Product Name
甲硝唑氯化钠注射液
Approval Number
国药准字H20123228
Approval Date
Aug 8, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.